|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.04 USD | +0.27% |
|
+3.72% | -42.55% |
Talaris Therapeutics, Inc. announced that executive team will be leaving the Company to pursue new opportunities. Scott Requadt will be leaving as President, effective May 26, 2023. Nancy Krieger will be leaving as Chief Medical Officer, effective April 28, 2023.
Michael Zdanowski will be leaving as Chief Technology Officer, effective April 28, 2023 and Andrew Farnsworth will be leaving as Chief Human Resources Officer, effective May 26, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -42.55% | 386M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
TOURMALINE BIO, INC. 